Literature DB >> 908475

Glucagon secretion in diabetic patients with idiopathic haemochromatosis.

P Passa, A S Luyckx, J L Carpentier, P J Lefebvre, J Canivet.   

Abstract

The aim of the present investigation was to determine in patients with idiopathic haemochromatosis whether diabetes is of the primary type or secondary to pancreatic injury due to iron deposition. For this purpose, plasma glucagon concentrations were determined following arginine infusion or an oral glucose load in eight patients with diabetes and idiopathic haemochromatosis. The enhanced glucagon response to arginine and the nonsuppressibility of glucagon secretion by oral glucose found in these patients were similar to the results found in the same tests performed in our previous series of patients with "idiopathic" diabetes and at variance with those reported by others in patients with chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908475     DOI: 10.1007/bf01234505

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Presence of diabetic glomerulosclerosis in patients with hemochromatosis.

Authors:  D BECKER; M MILLER
Journal:  N Engl J Med       Date:  1960-08-25       Impact factor: 91.245

3.  Absence of intercapillary glomerulosclerosis in the diabetic patient with hemochromatosis.

Authors:  P LONERGAN; S L ROBBINS
Journal:  N Engl J Med       Date:  1959-02-19       Impact factor: 91.245

4.  [Comparison of glucagon secretions in diabetes mellitus with or without acquired organic pancreatopathy].

Authors:  R Assan; A Tiengo
Journal:  Pathol Biol (Paris)       Date:  1973-01

5.  Abnormalities of glucagon metabolism in untreated diabetes mellitus.

Authors:  K D Buchanan; A M McCarroll
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

6.  Determination of pancreatic and gut glucagon-like immunoreactivity (GLI) in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1972-12       Impact factor: 10.122

7.  Control of pancreatic glucagon secretion by glucose.

Authors:  A Ohneda; E Aguilar-Parada; A M Eisentraut; R H Unger
Journal:  Diabetes       Date:  1969-01       Impact factor: 9.461

8.  [Idiopathic hemochromatosis and diabetes].

Authors:  R Saddi; J Feingold
Journal:  Rev Fr Etud Clin Biol       Date:  1969-03

9.  Glucagon secretion in acute and chronic pancreatitis.

Authors:  M Donowitz; R Hendler; H M Spiro; H J Binder; P Felig
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

10.  Pancreatectomised man: A model for diabetes without glucagon.

Authors:  A J Barnes; S R Bloom
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

View more
  5 in total

1.  Diabetes mellitus in idiopathic haemochromatosis.

Authors:  C H Walsh; J M Malins; S R Bloom
Journal:  Br Med J       Date:  1978-11-04

2.  Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

Authors:  C Niederau; M Berger; W Stremmel; A Starke; G Strohmeyer; R Ebert; E Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

3.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study.

Authors:  J Rahier; S Loozen; R M Goebbels; M Abrahem
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

4.  Plasma glucagon in diabetes of haemochromatosis: too low or too high?

Authors:  W A Muller; M Berger; H J Cüppers; P Berchtold; G Strohmeyer; A E Renold; J R Hofstetter; J J Gonvers
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

Review 5.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.